US Patent 8501756 Heterobicyclic carboxamides as inhibitors for kinases
Patent 8501756 was granted and assigned to Novartis on August, 2013 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
September 13, 2012
Date of Patent
August 6, 2013
Patent Application Number
13613062
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 8501756 Heterobicyclic carboxamides as inhibitors for kinases
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
